BioNTech (ADR)
Develops oncology medicines while commercializing the Pfizer-partnered Comirnaty vaccine.
$102.50
After-hours close+0.41 (+0.40%)
At close$102.09(−8.36%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 18.77%47.14M sharesInsiders 16.57%41.61M sharesOther 64.66%162.45M shares
Shares outstanding 251.20M · Float —
Float — provider float is below the insider stake.
The provider's float is smaller than the insider stake it should exclude, so it is not shown.
Institutions13F, as of Jun 30, 2026
317 holders · 47.14M shares · 46 new positions · 139 increased · 72 reduced · 32 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 7.57M | 3.01% | +1.86M | Aug 13, 2026 |
| Primecap Management Co/CA/ | 3.77M | 1.50% | −21.7K | Aug 14, 2026 |
| Dodge & Cox | 3.68M | 1.46% | +800 | Aug 13, 2026 |
| Flossbach von Storch AG | 2.23M | 0.89% | −1.45M | Aug 10, 2026 |
| T. Rowe Price Investment Management, Inc. | 2.07M | 0.82% | −3.79M | Aug 14, 2026 |
| BlackRock, Inc. | 1.85M | 0.74% | +196.8K | Aug 7, 2026 |
| Temasek Holdings (Private) Ltd | 1.51M | 0.60% | 0 | Aug 7, 2026 |
| BNP Paribas Arbitrage, SNC | 1.32M | 0.53% | −332.3K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Athos KG | 40.20% | 101.70M | 13G | May 14, 2026 ↗ |
| Ugur Sahinincl. Medine GmbH | 15.80% | 40.08M | 13G | May 15, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Ugur Sahin | 10 percent owner, officer: Chief Executive Officer | 40.08M | 15.95% | Apr 13, 2026 |
| Helmut Wolfgang Jeggle | director | 989.3K | 0.39% | Mar 18, 2026 |
| Sierk Poetting | officer: Chief Operating Officer | 540.9K | 0.22% | Apr 23, 2026 |
| James Timothy Patrick Ryan | officer: See remarks. | 4.8K | 0.00% | Mar 25, 2026 |
| Ulrich Wandschneider | director | 1.9K | 0.00% | Mar 18, 2026 |
| Rudolf Staudigl | director | 400 | 0.00% | Mar 25, 2026 |
| Anja Morawietz | director | 240 | 0.00% | Mar 25, 2026 |
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 22, 2026 | Sierk Poettingofficer: Chief Operating Officer | Sale | 50,000 | $110.56 | 399,387 |
CongressHouse and Senate disclosures
Not reported.